Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 117

Results For "CEO"

2217 News Found

Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions


Health Minister Mandaviya invites Japanese pharma companies to invest in India
Policy | May 16, 2023

Health Minister Mandaviya invites Japanese pharma companies to invest in India

The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030


Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
News | May 13, 2023

Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr

Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023


Gilead acquires XinThera to strengthen pipeline in oncology
News | May 12, 2023

Gilead acquires XinThera to strengthen pipeline in oncology

Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors


FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
News | May 11, 2023

FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS

Lucid-MS is a new drug candidate for the treatment of multiple sclerosis


Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023
News | May 10, 2023

Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023

The Awards recognizes standout digital health & medical technology products and companies


Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds
News | May 10, 2023

Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds

ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer


Galmed Pharmaceuticals forms partnership with OnKai
News | May 08, 2023

Galmed Pharmaceuticals forms partnership with OnKai

Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications


Wacker acquires Spain-based biotech firm ADL BioPharma
News | May 08, 2023

Wacker acquires Spain-based biotech firm ADL BioPharma

The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters


Lupin to acquire French pharmaceutical company Medisol
News | May 07, 2023

Lupin to acquire French pharmaceutical company Medisol

The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU